维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Sim SC"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Xanthones from Hypericum ascyron 显示文摘	Hu LH Yip SC Sim KY	1999	52:13711999，52，：	1
2	TH1 and TH2 cytokine mRNA profile in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse显示文摘	Yap HK Cheung W Murugasu B Sim SK Seah CC Jordan SC	1999	J Am Soc Nephrol1999，10，3：	1
3	CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7 * 1C allele显示文摘	Sim SC Edwards RJ Boobis AR	2005	Phacmacogenet Genomics2005，15，9：	1
4	Influence of cytochrome P450 polymorphisms on drug therapies:pharmacogenetic, pharmacoepigenetic and clinical aspects显示文摘	Ingelman-Sundberg M Sim SC Gomez A	2007	Pharmacol Ther2007，116，3：	1
5	Intronic polymorphisms of cytochromes P450显示文摘	Ingelman-Sundberg M Sim SC	2010	Hum Genomics2010，4，6：	1
6	A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants 显示文摘	Sim SC Risinger C Dahl ML	2006	Clin Pharmacol Ther2006，79，1：	1
7	A common novel CYP2C19 gene variant causes ultrarapid drug metabolism rele- vant for the drug response to proton pump inhibitors and anti-depressants显示文摘	SIM SC RISINGER C DAHL ML	2006	Clin Pharmacol Ther2006，79，1：	1
8	I Intercomparison of recruitment m - aneuver ef- ficacy in three models of acute lung injury 显示文摘	Lim SC Adam a AB Sim onson DA eta	2004	Crit Care Med2004，32，：	1
9	Influ- ence of cytochrome P450 polymorphisms on drug therapies : phar- macogenetic, pharmacoepigenetic and clinical aspects显示文摘	INGELMAN-SUNDBERG M SIM SC GOMEZ A	2007	Phar- macol Ther2007，116，3：	1
10	Influence of cytochrome P450 polymorphisms on drug therapies:pharmacogenetic,pharmacoepigenetic and clinical aspects显示文摘	Ingelman-Sundberg M Sim SC Gomez A	2007	Pharmacol Ther2007，116，：	1
11	A common novel CYP2C19 gene variant causes ultrarapid drug response to proton pump inhibitors and antidepressants 显示文摘	Sim SC Risinger C Dahl ML	2006	Clin Pharmacol Ther2006，79，1：	1
12	A common novel CYP2C19gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants显示文摘	Sim SC Risinger C Dahl ML	2006	Clin Pharmacol Ther2006，79，：	1
13	Unique TGFBI protein in lattice corneal dystrophy显示文摘	Han YP Sim AJ Vora SC	2011	Invest Ophthahnol Vis Sei2011，52，11：	1
14	Nomenclature for alleles of the cytochrome p450 oxidoreductase gene 显示文摘	Sim SC Miller WL Zhong XB	2009	Pharmacogenet Genomics2009，19，7：	1
15	Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees显示文摘	Hollander AP Dickinson SC Sims TJ	2006	Tissue Eng2006，12，7：	1
16	A common novel CYP2C19 gene variant causes ultrarapiddrug metabolism relevant for the drug response to proton pump inhibitors and antid epressants显示文摘	Sim SC Risinger C Dahl ML	2006	Clin Pharmacol Ther2006，79，：	1
17	A common novel CYP2C19 gene variant causes uhrarapid drug metabolism rel evant for the drug response to proton pump inhibitors and an- tidepressants显示文摘	Sim SC Risinger C Dahl ML	2006	Clin Pharmacol Ther2006，79，1：	1
18	SCIP/Oct 6,Krox 20,and desert hedgehorm RNA expression during CNS remyelination by transplanted olfactory ensheathing cells显示文摘	Smith PM Sim FJ Barnett SC	2001	Glia2001，36，3：	1
19	Influence of cyto- chromeP450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects 显示文摘	Ingelman-Sundberg M Sim SC Gomez A	2007	Pharmacol Ther2007，116，3：	1
20	Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinic',d aspects显示文摘	INGELMAN-SUNDBERG M SIM SC GOMEZ A	2007	Pharmacol Ther2007，116，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示